Soo‐Yong Tan

Agency for Science, Technology and Research — Singapore

Medicine · Health Sciences

38h-index5.8kcitations233works2.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lymphoma Diagnosis and Treatment(102), Viral-associated cancers and disorders(27), Chronic Lymphocytic Leukemia Research(22), Cancer Genomics and Diagnostics(20), Immune Cell Function and Interaction(19)

Publications232 total

Supplementary appendix from Patterns of Oncogene Coexpression at Single-Cell Resolution Influence Survival in Lymphoma
2025Open Access
Supplementary tables from Patterns of Oncogene Coexpression at Single-Cell Resolution Influence Survival in Lymphoma
2025Open Access
Supplementary file from Targeting RNA Exonuclease XRN1 Potentiates Efficacy of Cancer Immunotherapy
2025Open Access
Elevated serum levels of GPX4, NDUFS4, PRDX5, and TXNRD2 as predictive biomarkers for castration resistance in prostate cancer patients: an exploratory study
British Journal of Cancer·2025· 3 citedOpen Access
Sociobiology meets oncology: unraveling altruistic cooperation in cancer cells and its implications
Experimental & Molecular Medicine·2025· 5 citedOpen Access
Machine Learning Classification of Spatial Patterns of Malignant Cells Reveals Implications in Prognosis and Tumor Microenvironment Composition in Lymphoma
Blood·2024· 1 citedOpen Access
Kikuchi-Fujimoto lymphadenitis in a patient with human immunodeficiency virus infection: The importance of precision pathology
International Journal of STD & AIDS·2024
Prebiotic stachyose inhibits PRDX5 activity and castration-resistant prostate cancer development
International Journal of Biological Macromolecules·2024· 3 cited
BD SurePath Direct to Slide (DTS) cervical cytology: Migrating the benefits of liquid-based cytology to low-resource settings
American Journal of Clinical Pathology·2024Open Access
A comprehensive AI model development framework for consistent Gleason grading
Communications Medicine·2024· 13 citedOpen Access
GDC-0214 Is a Potent Inhaled JAK Inhibitor With Efficacy in Multiple Pre-clinical Models of Th2 Inflammation: A Perspective on Use of In Vivo Rodent Models for Early Phase Drug Discovery
2024· 1 cited
Abstract P21: Single Cell Resolution Spatial Modeling Uncovers Survival-associated Phenotypes in Diffuse Large B Cell Lymphoma
Cancer Research·2024
MicroRNA expression signature as a biomarker in the diagnosis of nodal T-cell lymphomas
Cancer Cell International·2024· 1 citedOpen Access
Identification of PRDX5 as A Target for The Treatment of Castration‐Resistant Prostate Cancer
Advanced Science·2023· 14 citedOpen Access
Dynamic altruistic cooperation within breast tumors
Molecular Cancer·2023· 11 citedOpen Access
<scp>miR</scp>‐101‐5p modulation of <scp>CD47</scp> in diffuse large B‐cell lymphoma: Implications for <scp>anti‐CD47</scp> immunotherapy and prognostication
British Journal of Haematology·2023· 1 citedOpen Access
WNTinib is a multi-kinase inhibitor with specificity against β-catenin mutant hepatocellular carcinoma
Nature Cancer·2023· 23 citedOpen Access
Figure 1 from Patterns of Oncogene Coexpression at Single-Cell Resolution Influence Survival in Lymphoma
2023Open Access
Figure 1 from Patterns of Oncogene Coexpression at Single-Cell Resolution Influence Survival in Lymphoma
2023Open Access
Figure 6 from Patterns of Oncogene Coexpression at Single-Cell Resolution Influence Survival in Lymphoma
2023Open Access
page 1 of 12Next →

Frequent Co-authors

Soon Thye Lim(18), Siok‐Bian Ng(11), Choon Kiat Ong(10), Wee Joo Chng(8), Yurike Laurensia(6), Bin Tean Teh(5), Jing Quan Lim(5), Tiffany Tang(5), Kevin Tay(5), Miriam Tao(5), Dachuan Huang(5), Burton Kuan Hui Chia(4), Daryl Ming Zhe Cheah(4), Jin‐Xin Bei(4), Leonard Tan(4), Mark B. Pepys(4), Oi Lian Kon(4), Anand D. Jeyasekharan(4), Shigeo Nakamura(3), Cheryl M. Koh(3)